FDA fast tracks psychadelic drug research following Trump's executive order, according to CNBC

The FDA's decision to fast track psychedelic drug research following Trump's executive order signals a potential shift in regulatory attitudes towards innovative therapies.

Newsquawk StaffPublished On the live feed at 10 more headlines followed before this page went public
Newsquawk headlinesUTC

Sources told Asharq that an American delegation will arrive in Islamabad within 36 hours in preparation for a second round of talks.

Al Arabiya correspondent says Iran FM Araqchi will discuss the renegotiation process tonight in Pakistan

FDA fast tracks psychadelic drug research following Trump's executive order, according to CNBC

Al-Mayadeen envoy to Islamabad says it cannot be said yet that Iranian Foreign Minister's meetings in Pakistan will be preparation for a new round of negotiations

White House didn’t immediately respond to questions on Iran’s foreign minister going to Pakistan, according to AP

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This could influence investor sentiment toward biotech equities and create ripple effects across sectors sensitive to regulatory changes, particularly in pharmaceuticals and mental health treatments.

Related headlines

The whole workspace, free to try.

Try it free